跳至主要内容
临床试验/NCT04114253
NCT04114253已完成不适用

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Liver Transplant

HemoSonics LLC1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Comparison of Quantra Clot Time results to TEG R results

研究概览

简要总结

This study will assess the clinical performance of the Quantra System with the QStat Cartridge in the liver transplant population.

详细描述

The Quantra System is a fully integrated and automated in vitro diagnostic device which uses SEER Sonorheometry, an ultrasound-based technology, to characterize the viscoelastic propoerties of a whole blood sample during coagulation. The Quantra QStat Cartridge was developed to monitor hemostasis in the trauma and liver transplant populations which may experience a range of coagulopathies of various etiologies including fibrinolytic defects.

This single-center, prospective, observational stuey will evaluate the performance of the Quantra System with the QStat Cartridge as compared to corresponding measures determined using the TEG 5000.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is ≥ 18 years of age
  • Subject is undergoing deceased donor liver transplant and is a candidate for a TEG test to be performed to access coagulopathy during surgery.
  • Subject is willing to participate, and is willing to consent (either prospectively or by deferred consent)

排除标准

  • Subject is younger than 18 years of age
  • Subject is known to have received antifibrinolytic therapy immediately prior to the start of liver transplantation surgery.
  • Subject is unable to provide written informed consent (either prior to performing any study related procedures or by deferred consent)
  • Subject is currently enrolled in a distinct study that might confound the results of the proposed study
  • Subject is affected by a condition that, in the opinion of the clinical team, may pose additional risks

结局指标

主要结局

Comparison of Quantra Clot Time results to TEG R results

时间窗: During surgery

Coagulation function assessed by Quantra and TEG 5000

Comparison of Quantra Clot Stiffness results to TEG MA results

时间窗: During surgery

Coagulation function assessed by Quantra and TEG 5000

Comparison of Quantra Clot Lysis results to TEG LI30 results

时间窗: During surgery

Coagulation function assessed by Quantra and TEG 5000

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验